Found 6 matching trials
Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno® PHASE1 Therapeutic indication: Ocular hypotensive Use: Primary open-angle glaucoma...
Show More Location
Unidad Clínica de Bioequivalencia, S. de R.L. de C.V.
Learn More & Join Trial
Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide PHASE2 To compare intraocular pressure lowering effectiveness of a new fixed combi...
Show More Location
Instituto de la Visión. Hospital Universitario La Carlota. Universidad de Montemorelos
Learn More & Join Trial
Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension. PHASE4 Phase IV randomized, double blind, multicenter, parallel group clinical stu...
Show More Location
Servicios Médicos y de Investigación Clínica InspirePharma S. de R.L.de C.V.
Learn More & Join Trial
Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT) N/A The objective of this phase IV clinical multi-center trial will be to compa...
Show More Location
Global Galucoma Institute
Learn More & Join Trial
PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM) PHASE3 Objectives: To evaluate the non-inferiority in the intraocular pressure dec...
Show More Location
MD. Sandra Belalcazar Rey
Learn More & Join Trial
Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK) PHASE3 Aim: To demonstrate the non-inferiority of the PRO-122 ophthalmic solution ...
Show More Location
Multiple Locations
Learn More & Join Trial